Oxycodone Controlled-Release as First-Choice Therapy for Moderate-to-Severe Cancer Pain in Italian Patients: Results of an Open-Label, Multicentre, Observational Study

By Silvestri Barbara  

Clinical Drug Investigation, Vol. 28, Iss. 7, 2008-01 ,pp. : 399-407

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Study

By Afilalo Marc  

Clinical Drug Investigation, Vol. 30, Iss. 8, 2010-08 ,pp. : 489-505

Adis International

Access to resources Recommend Favorite

Oxycodone CR is effective for moderate to severe cancer pain

By  

Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Analgesic Efficacy and Tolerability of Tramadol 100mg Sustained-Release Capsules in Patients with Moderate to Severe Chronic Low Back Pain

By Raber M.  

Clinical Drug Investigation, Vol. 17, Iss. 6, 1999-06 ,pp. : 415-423

Adis International

Access to resources Recommend Favorite

Tramadol Extended-Release Tablets in Moderate to Moderately Severe Chronic Pain in Adults: Profile Report

By Hair Philip I.   Curran Monique P.   Keam Susan J.  

CNS Drugs, Vol. 21, Iss. 3, 2007-01 ,pp. : 259-263

Adis International

Access to resources Recommend Favorite